Novo Nordisk Sees Diabetes Drug Market Expanding

Novo Nordisk Sees Diabetes Drug Market Expanding Play

April 27 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about first-quarter profit and the outlook for the world's largest insulin maker. He speaks from Copenhagen with Maryam Nemazee on Bloomberg Television's "The Pulse." (Source: Bloomberg)

  • On Air Now

    Poker Night on Wall Street Watch Now

  • Next

    Studio 1.0: Reid Hoffman

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus